A Study of Dasatinib (BMS-354825) in Patients With Advanced 'Triple-negative' Breast Cancer
Clinical trial NCT00371254 · COMPLETED
Trial details
- NCT number
- NCT00371254
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2008-09-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.